DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+11.8%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.54B
AUM Growth
+$2.54B
(+8.3%)
Cap. Flow
+$23M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
37.92%
Holding
129
New
21
Increased
16
Reduced
23
Closed
20
Top Buys
| 1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$38M |
| 2 |
ADPT
Adeptus Health Inc.
ADPT
|
$33.3M |
| 3 |
DBVT
DBV Technologies
DBVT
|
$30.2M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$29.1M |
| 5 |
Glaukos
GKOS
|
$28.7M |
Top Sells
| 1 |
GSK
GSK
|
$67.9M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$35.7M |
| 3 |
AET
Aetna Inc
AET
|
$27.5M |
| 4 |
McKesson
MCK
|
$27.5M |
| 5 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
$27.4M |
Sector Composition
| 1 | Healthcare | 68.67% |
| 2 | Financials | 3.21% |
| 3 | Industrials | 0.75% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
26
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $28.8M | 1.13% |
1,733,828
+540,017
| +45% | +$8.96M |
|
|
27
Glaukos
GKOS
$5.42B
| $28.7M | 1.13% |
+984,112
| New | +$28.7M |
|
28
Humana
HUM
$37.5B
| $28.7M | 1.13% |
+159,500
| New | +$28.7M |
|
|
ACOR
29
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $26.3M | 1.03% |
1,029,410
| – | – |
|
30
Galapagos
GLPG
$2.06B
| $25.4M | 1% |
458,112
+130,486
| +40% | +$7.24M |
|
31
Axogen
AXGN
$718M
| $23.3M | 0.91% |
3,381,439
| – | – |
|
32
Cigna
CI
$80.2B
| $21.9M | 0.86% |
+171,000
| New | +$21.9M |
|
33
Molina Healthcare
MOH
$9.6B
| $21.8M | 0.86% |
+436,000
| New | +$21.8M |
|
|
LCI
34
DELISTED
Lannett Company, Inc.
LCI
| $21.3M | 0.84% |
+895,591
| New | +$21.3M |
|
|
RAD
35
DELISTED
Rite Aid Corporation
RAD
| $19.6M | 0.77% |
2,611,580
+218,508
| +9% | +$1.64M |
|
|
COTV
36
DELISTED
Cotiviti Holdings, Inc.
COTV
| $19M | 0.75% |
+900,079
| New | +$19M |
|
|
ONCE
37
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $18.8M | 0.74% |
+368,000
| New | +$18.8M |
|
38
Alnylam Pharmaceuticals
ALNY
$58.6B
| $18.6M | 0.73% |
+336,000
| New | +$18.6M |
|
|
FPRX
39
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $18.5M | 0.73% |
448,000
-232,000
| -34% | -$9.59M |
|
40
Larimar Therapeutics
LRMR
$337M
| $18.3M | 0.72% |
3,055,603
| – | – |
|
|
ALPN
41
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $17.2M | 0.67% |
3,732,412
| – | – |
|
|
AKTX
42
Akari Therapeutics
AKTX
$21.4M
| $15.5M | 0.61% |
1,150,700
| – | – |
|
|
BLUE
43
DELISTED
bluebird bio
BLUE
| $14.6M | 0.58% |
+338,085
| New | +$14.6M |
|
44
Select Medical
SEM
$1.6B
| $14.3M | 0.56% |
1,316,944
+757,847
| +136% | +$8.24M |
|
|
IVTY
45
DELISTED
Invuity, Inc
IVTY
| $12.6M | 0.5% |
1,327,009
| – | – |
|
46
Protara Therapeutics
TARA
$125M
| $12.5M | 0.49% |
1,552,031
+286,688
| +23% | +$2.3M |
|
47
CytomX Therapeutics
CTMX
$350M
| $9.64M | 0.38% |
943,433
| – | – |
|
48
Regenxbio
RGNX
$498M
| $9.35M | 0.37% |
1,169,042
| – | – |
|
|
NSTG
49
DELISTED
NanoString Technologies, Inc.
NSTG
| $8.5M | 0.33% |
674,622
+68,400
| +11% | +$862K |
|
|
FOMX
50
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $8.14M | 0.32% |
1,282,058
+333,124
| +35% | +$2.12M |
|